| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $37.8M | $46.4M | $53.3M |
| YoY Revenue Growth % | -18.6% | -12.8% | — |
| Gross Profit | $15.4M | $14.6M | — |
| Gross Margin % | 40.8% | 31.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$7.9M | -$27.4M | -$6.6M |
| Operating Margin % | -21.0% | -59.0% | -12.5% |
| Net Income (GAAP) | -$18.4M | -$39.5M | -$15.3M |
| EBITDA (Normalized) | -$7.6M | -$26.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.9M | $3.5M | -$15.3M |
| Capital Expenditures (CapEx) | $479.0K | $576.7K | — |
| Free Cash Flow (FCF) | $7.4M | $2.9M | -$15.3M |
| FCF Margin % | 19.5% | 6.2% | -28.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $75.2M | $63.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$5.7M | -$66.0M | — |